The Number Is the Symptom

When a business misses the number, the number gets all the attention.

Bookings are behind. Pipeline is light. Win rates are down. Growth slowed. Expansion isn't happening fast enough.

The natural response is to attack the metric.

Push the sales team harder. Add pipeline targets. Increase activity. Change compensation. Hire more reps. Replace a leader. Launch another campaign.

Sometimes one of those moves is right.

But I've learned to be careful with the first answer, because the problem is rarely just the number.

The number is an outcome.

A revenue result sits at the end of a much larger system.

Market. Product. Positioning. Ideal customer profile. Pricing. Demand generation. Sales execution. Leadership. Talent. Incentives. Customer experience. Operating cadence. Forecast discipline. Organizational design.

All of those things can eventually show up in the same place: the number.

That means two companies can miss the exact same growth target for completely different reasons.

One may have a sales execution problem. Another may have a market problem. Another may have built a plan that was never realistic. Another may be selling a good product to the wrong buyer. Another may have plenty of opportunity but a leadership team that cannot make decisions quickly enough to convert it.

If the diagnosis is wrong, working harder on the metric can make the business busier without making it better.

Diagnose before you prescribe.

This sounds obvious in theory. In practice, organizations prescribe constantly.

The board wants more pipeline, so marketing gets a larger lead target. The pipeline exists but isn't converting, so sales gets more pressure. Sales says the product is the issue, product says positioning is the issue, marketing says follow-up is the issue.

Everyone can be directionally right and still miss the actual constraint.

Before changing the system, I want to understand where the system is breaking.

Is there enough demand in the target market? Are we creating enough qualified opportunities? Are the opportunities real? Are we reaching the right economic buyer? Does the value proposition create urgency? Does the product solve a problem worth changing behavior for? Are sellers able to articulate that value? Are deals advancing because customers are buying—or because our CRM says the stage changed?

Then I want to understand the organization around those questions.

Do leaders agree on the problem? Are incentives reinforcing the strategy? Do teams know what good looks like? Is accountability clear? Are decisions being made at the right level? Does the operating cadence expose problems early enough to do something about them?

Only then does a prescription become useful.

Pressure is not diagnosis.

One of the easiest traps in a missed-plan environment is confusing intensity with progress.

More forecast calls. More deal reviews. More executive emails. More requests for updates. More scrutiny on every opportunity.

That can create motion. It can also create noise.

If the fundamental issue is weak product-market fit, an extra pipeline call won't fix it. If the plan requires a conversion rate the business has never demonstrated, pushing sellers harder doesn't change the math. If customers don't understand why they need to act now, inspecting close dates won't manufacture urgency.

Leadership pressure can be useful when it sharpens focus around something controllable.

It becomes destructive when it substitutes for understanding.

Start with the constraint.

When I enter a business or a commercial problem, I try to resist the temptation to prove value by producing answers quickly.

The first job is to understand.

What is happening? What should be happening? Where does the gap begin? What evidence supports that? What are we assuming? What would have to be true for the current plan to work?

Those questions are less satisfying than immediately announcing a new strategy. They're also usually more valuable.

Once the constraint is visible, the work gets much clearer.

Maybe sales needs a different operating system. Maybe marketing needs to narrow the market. Maybe pricing needs to change. Maybe a leader needs coaching. Maybe the organization needs different talent. Maybe the company needs to stop pretending a product is ready to scale.

Or maybe the team is doing many of the right things and simply needs enough time for those decisions to compound.

Different diagnosis. Different prescription.

The number still matters.

None of this is an argument for explaining away performance.

I've spent my career responsible for the number. Results matter. Accountability matters. Businesses eventually have to produce outcomes.

But accountability without diagnosis is often just pressure.

The job of a commercial leader isn't merely to demand a better result. It's to understand the system producing the current one and improve it.

The number tells you something is happening.

The work is figuring out why.